Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients
Article in Frontiers in Endocrinology (July 2023)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Article in Frontiers in Endocrinology (July 2023)
Article in International Journal of Preventive Medicine (July 2023)
Article in European Urology (May 2023)